| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | PUMA BIOTECHNOLOGY | 17,500 | 2,043,000 | 0.66% | ||
| 52 | TONIX PHARMACEUTICALS HLD | 202,500 | 1,816,000 | 0.59% | ||
| 53 | RADIUS HEALTH | 25,000 | 1,693,000 | 0.55% | ||
| 54 | VERSARTIS INC COM | 100,000 | 1,522,000 | 0.49% | ||
| 55 | ADAPTIMMUNE THERAPEUTICS PLC | 76,850 | 1,409,000 | 0.46% | ||
| 56 | Ascendis Pharma | 63,739 | 1,127,000 | 0.37% | ||
| 57 | UNILIFE CORP | 450,000 | 968,000 | 0.31% | ||
| 58 | VERACYTE INC | 78,386 | 873,000 | 0.28% | ||
| 59 | BioDelivery Sciences International Inc | 106,200 | 845,000 | 0.27% | Call | |
| 60 | Nivalis Therapeutics Inc | 50,000 | 758,000 | 0.25% | ||
| 61 | BIOCRYST PHARMACEUTICALS | 45,000 | 672,000 | 0.22% | ||
| 62 | KINDRED BIOSCIENCES INC | 93,500 | 638,000 | 0.21% | ||
| 63 | BIOLASE INC | 300,000 | 522,000 | 0.17% | ||
| 64 | XOMA CORP DEL | 125,000 | 485,000 | 0.16% | ||
| 65 | OCERA THERAPEUTICS INC | 125,000 | 475,000 | 0.15% | ||
| 66 | GLAUKOS CORP | 15,000 | 435,000 | 0.14% | ||
| 67 | XENON PHARMACEUTICALS INC | 37,500 | 432,000 | 0.14% | ||
| 68 | Neothetics Inc | 43,000 | 387,000 | 0.13% | ||
| 69 | AVALANCHE BIOTECHNOLOGIES IN | 15,000 | 244,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-15-034669, filed 2015.09.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
